A detailed history of Phoenix Wealth Advisors transactions in Amgen Inc stock. As of the latest transaction made, Phoenix Wealth Advisors holds 2,693 shares of AMGN stock, worth $860,628. This represents 0.42% of its overall portfolio holdings.

Number of Shares
2,693
Previous 2,732 1.43%
Holding current value
$860,628
Previous $776,000 8.38%
% of portfolio
0.42%
Previous 0.47%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$262.75 - $319.31 $10,247 - $12,453
-39 Reduced 1.43%
2,693 $841,000
Q1 2024

Apr 26, 2024

SELL
$268.87 - $324.56 $1,075 - $1,298
-4 Reduced 0.15%
2,732 $776,000
Q4 2023

Jan 30, 2024

SELL
$255.7 - $288.46 $2,301 - $2,596
-9 Reduced 0.33%
2,736 $788,000
Q3 2023

Nov 06, 2023

BUY
$218.65 - $271.46 $7,434 - $9,229
34 Added 1.25%
2,745 $737,000
Q2 2023

Jul 13, 2023

SELL
$214.27 - $253.37 $5,999 - $7,094
-28 Reduced 1.02%
2,711 $601,000
Q1 2023

May 05, 2023

SELL
$225.79 - $275.2 $14,450 - $17,612
-64 Reduced 2.28%
2,739 $662,000
Q4 2022

Feb 06, 2023

SELL
$229.03 - $291.01 $99,857 - $126,880
-436 Reduced 13.46%
2,803 $736,000
Q3 2022

Nov 07, 2022

SELL
$224.46 - $253.15 $48,034 - $54,174
-214 Reduced 6.2%
3,239 $730,000
Q2 2022

Aug 01, 2022

BUY
$230.71 - $256.74 $13,611 - $15,147
59 Added 1.74%
3,453 $840,000
Q1 2022

May 02, 2022

SELL
$219.27 - $242.57 $51,747 - $57,246
-236 Reduced 6.5%
3,394 $848,000
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $16,507 - $18,890
-83 Reduced 2.24%
3,630 $817,000
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $108,257 - $126,837
-510 Reduced 12.08%
3,713 $790,000
Q2 2021

Jul 23, 2021

BUY
$233.58 - $259.14 $31,533 - $34,983
135 Added 3.3%
4,223 $1.03 Million
Q1 2021

Apr 12, 2021

BUY
$221.91 - $258.6 $143,575 - $167,314
647 Added 18.8%
4,088 $1.02 Million
Q4 2020

Feb 05, 2021

BUY
$216.38 - $257.67 $744,563 - $886,642
3,441 New
3,441 $791,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Phoenix Wealth Advisors Portfolio

Follow Phoenix Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Phoenix Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Phoenix Wealth Advisors with notifications on news.